Free Trial

Swiss National Bank Trims Position in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background
Remove Ads

Swiss National Bank trimmed its position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 4.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 165,600 shares of the company's stock after selling 8,300 shares during the quarter. Swiss National Bank owned approximately 0.29% of Molina Healthcare worth $48,198,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of MOH. Janney Montgomery Scott LLC boosted its position in Molina Healthcare by 3.0% during the 3rd quarter. Janney Montgomery Scott LLC now owns 2,509 shares of the company's stock valued at $865,000 after acquiring an additional 72 shares in the last quarter. Victory Capital Management Inc. boosted its position in Molina Healthcare by 6.5% during the 3rd quarter. Victory Capital Management Inc. now owns 94,834 shares of the company's stock valued at $32,676,000 after acquiring an additional 5,751 shares in the last quarter. Metis Global Partners LLC boosted its position in Molina Healthcare by 1.4% during the 3rd quarter. Metis Global Partners LLC now owns 2,785 shares of the company's stock valued at $960,000 after acquiring an additional 39 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its position in Molina Healthcare by 3.5% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,705 shares of the company's stock valued at $587,000 after acquiring an additional 57 shares in the last quarter. Finally, CIBC Asset Management Inc boosted its position in Molina Healthcare by 8.3% during the 3rd quarter. CIBC Asset Management Inc now owns 8,537 shares of the company's stock valued at $2,942,000 after acquiring an additional 652 shares in the last quarter. 98.50% of the stock is owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

Several research firms have recently issued reports on MOH. Wells Fargo & Company upgraded shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. UBS Group lowered their target price on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a report on Friday, February 7th. Mizuho lowered their target price on shares of Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $350.00 target price (down from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Finally, Barclays lowered their price objective on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a research report on Friday, February 7th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Molina Healthcare presently has an average rating of "Hold" and a consensus price target of $355.69.

View Our Latest Research Report on MOH

Insider Buying and Selling

In related news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the sale, the director now directly owns 17,375 shares in the company, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.10% of the stock is owned by corporate insiders.

Molina Healthcare Stock Performance

Shares of NYSE MOH traded up $0.73 during midday trading on Thursday, hitting $315.60. 565,297 shares of the company's stock traded hands, compared to its average volume of 756,313. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $423.92. The stock has a market capitalization of $17.52 billion, a price-to-earnings ratio of 15.45, a price-to-earnings-growth ratio of 1.06 and a beta of 0.56. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The firm has a fifty day moving average of $298.86 and a 200 day moving average of $309.90.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. On average, analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Further Reading

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads